Search research articles
Contact Us
Filters
Showing results (91-100 of 161) with videos related to
Page
of 17
Sort By:
The Journal of Infectious Diseases
|
June 25, 2004
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients
Martin S King, Barry M Bernstein, Sharon L Walmsley, et al.
Journal of Substance Use and Addiction Treatment
|
May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing code
Gayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
Journal of General Internal Medicine
|
November 7, 2006
Spirituality and religion in patients with HIV/AIDS
Sian Cotton, Christina M Puchalski, Susan N Sherman, et al.
Science Translational Medicine
|
August 8, 2014
Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients
Kenneth E Sherman, Jeremie Guedj, Mohamed Tarek Shata, et al.
Journal of Clinical Medicine
|
November 11, 2022
Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders
Viviana E Horigian, Renae D Schmidt, Dikla Shmueli-Blumberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 15, 2022
Principles for Ending Human Immunodeficiency Virus as an Epidemic in the United States: A Policy Paper of the Infectious Diseases Society of America and the HIV Medical Association
Anna K Person, Wendy S Armstrong, Tyler Evans, et al.
Plos One
|
November 22, 2013
The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit
David A Wohl, Michelle A Kendall, Judith Feinberg, et al.
AIDS (London, England)
|
February 9, 2002
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients
Judith Falloon, Mounir Ait-Khaled, Deborah A Thomas, et al.
Lancet (London, England)
|
April 5, 2014
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Bonaventura Clotet, Judith Feinberg, Jan van Lunzen, et al.
Frontiers in Public Health
|
June 1, 2023
High suicidality predicts overdose events among people with substance use disorder: A latent class analysis
Renae D Schmidt, Viviana E Horigian, Dikla Shmueli-Blumberg, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 161) with videos related to
Sort By:
Page
of 17
The Journal of Infectious Diseases
|
June 25, 2004
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients
Martin S King, Barry M Bernstein, Sharon L Walmsley, et al.
Journal of Substance Use and Addiction Treatment
|
May 12, 2024
Perspectives on benefits and risks of creation of an "injection drug use" billing code
Gayathri Sundaram, Taisuke Sato, David Goodman-Meza, et al.
Journal of General Internal Medicine
|
November 7, 2006
Spirituality and religion in patients with HIV/AIDS
Sian Cotton, Christina M Puchalski, Susan N Sherman, et al.
Science Translational Medicine
|
August 8, 2014
Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients
Kenneth E Sherman, Jeremie Guedj, Mohamed Tarek Shata, et al.
Journal of Clinical Medicine
|
November 11, 2022
Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders
Viviana E Horigian, Renae D Schmidt, Dikla Shmueli-Blumberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 15, 2022
Principles for Ending Human Immunodeficiency Virus as an Epidemic in the United States: A Policy Paper of the Infectious Diseases Society of America and the HIV Medical Association
Anna K Person, Wendy S Armstrong, Tyler Evans, et al.
Plos One
|
November 22, 2013
The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit
David A Wohl, Michelle A Kendall, Judith Feinberg, et al.
AIDS (London, England)
|
February 9, 2002
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients
Judith Falloon, Mounir Ait-Khaled, Deborah A Thomas, et al.
Lancet (London, England)
|
April 5, 2014
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Bonaventura Clotet, Judith Feinberg, Jan van Lunzen, et al.
Frontiers in Public Health
|
June 1, 2023
High suicidality predicts overdose events among people with substance use disorder: A latent class analysis
Renae D Schmidt, Viviana E Horigian, Dikla Shmueli-Blumberg, et al.
Page
of 17